Tappe fondamentali della storia della Biohit

YearEvents
Net Sales EUR million
2014New products: Calprotectin test for diagnosis and monitoring of inflammatory bowel diseases, 
Biohit Active B12 test to diagnosis of B12 vitamin deficiency
2013Subsidiary in Italy
Joint Venture in China, Biohit Healthcare (Hefei) Co. Ltd.
3.5
2012International patents, incl. US, China, Europatent2.0
2011Launch of the unique Acetium® capsule that reduces carcinogenic acetaldehyde in the stomach
Establishment of a representative office in Singapore
Semi Korpela appointed new President & CEO of Biohit Group
2.2
2010Launch of the Acetium capsule that reduces carcinogenic acetaldehyde in anacidic stomach
Establishment of a representative office in Singapore
40.0
2009
Establishement of Biohit subsidiary in India
Launch of Pipetting Academy
Launch of SafetySpace™ Filter Tips
Renewal of product packages
Accreditation of Biohit’s pipette calibration laboratory in Russia
35.4
2008
20th Anniversary of Biohit
Launch of ColonView faecal occult blood test
Launch of new filter tips
Accreditation of Biohit’s calibration laboratory in Germany
35.1
2007
Launch of the new Proline Plus mechanical pipette range
Launch of GastroView (3-in-1 Indigestion Test) in the UK
Agrrement with VWR concerning liquid handling product sales in Europe   
32.7
2006
Liquid Handling business receives ISO 13485 certification (CE/IVD compliance)
Biohit opens subsidiary and starts pipette assembly in China
Launch of the electronic eLINE Dispenser for multiple dispensing
Chinese scientists recommend GastroPanel for use in Chinese health care
Biohit announces its new products that reduce carcinogenic acetaldehyde in the mouth and stomach
Launch of the Helicobacter pylori IgA/IgG ELISA test
31.4
2005
China´s State Food and Drug Administration (SFDA) granted Biohit a marketing authorization for the Pepsinogen I & II and Gastrin-17 tests included in the GastroPanel examination
New contracts help strengthen the company’s OEM business
28.6
2004
Launch of the multichannel mechanical mLINE pipettes
Launch of quick tests for diagnosis of Helicobacter pylori infection and lactose intolerance
The US Food and Drug Administration (FDA) approval for the GastroPanel test kit’s serum-based H. pylori test
Prize awarded to Biohit by VWR USA, one of the largest global distributors of liquid handling products
26.7
2003
Launch of the multichannel electronic eLINE pipettors
Establishement of Biohit’s representative office in China
Further development of the production at the Kajaani plant
Diagnostics business receives ISO 13485 certification and CE/IVD compliance
26.2
2002
Launch of the new mLINE mechanical pipettor range
Enlargement of the electronic eLINE pipettor product range
Continuation of the automatisation at the production premises in Kajaani
Biohit opens a subsidiary in Russia
25.3
2001
Marketing of the GastroPanel began for research use and several clinical evaluations are being carried out
Development of test kit for cellular fibronectin (cFn)
Completion of new production premises for diagnostics in Helsinki, Finland Service laboratory operations start.
25.5
2000
Completion of new production premises in Kajaani
Accreditation of Biohit’s pipette calibration laboratory in Finland
Preparation to commence the global marketing and sales of diagnostic tests and analyzing systems
Commencement of the sales of instruments
Reinforcement of international collaboration and customer service organization through acquisitions in the US and Russia
24.2
1999
Listing on Helsinki Exchanges (New Market list)
Continuation of the aggressive patenting policy
20.5
1998
Assembling of pipettors and injection moulding begins in Helsinki
Locus genex Oy and Biohit Systems, Inc. become Biohit Group companies
External evaluation of the first test kit (Pepsinogen I) of the GastroPanel program
Ph.D. Thesis of Auli Linnala: Basic research on Biohit’s monoclonal antibodies (cFn and tenascin), which are related with cancer diagnostics
16.8
1997
Moving into new facilities in Helsinki
ISO 9001 quality system certification
Co-operation with Becton Dickinson and 3M begins
Receiving EUREKA[2] status on the basis of which TEKES funding received for the GastroPanel program    
14.4
1996
Reinforcement of international sales and marketing
The GastroPanel program begins
Ph.D. Thesis of Sari Ylätupa: An application invention of vertical measurement and immunoassays; the determination of cFn from blood samples and its importance in cancer diagnostics
12.6
1995
Launch of several new liquid handling products
Establishment of a Biohit subsidiary in Germany
Co-operation with Eastman Kodak Co. Clinical Diagnostic Systems, later acquired by Johnson & Johnson begins
10.5
1994
Development of the renewed electronic pipettor
Co-operation with Ortho Diagnostic Systems of Johnson & Johnson begins
Establishment of joint venture in Japan
Ph.D. Thesis of Osmo Suovaniemi: The vertical measurement invention, its applications and the invention of electronic liquid handling devices
8.4
1993
Launch of the multichannel Proline mechanical pipette
Co-operation regarding liquid handling products with Eppendorf and bioMérieux begins
6.4
1992
Launch of the Proline mechanical pipette
Launch of the multichannel Proline electronic pipettor
Establishment of subsidiaries in Italy and the UK
Ph.D. Thesis of Tapani Tiusanen: An application invention of vertical measurement; the self-correcting, multiparameter measuring instrument
4.2
1991
TEKES funding for the development of mechanical pipettors
Establishment of the first Biohit subsidiary, in France
Introduction of new monoclonal antibodies
2.1
1990
Worldwide introduction of the first ergonomically designed electronic pipettor, the Proline
Assembling of pipettors and injection moulding begins in Kajaani, Finland
Introduction of first monoclonal antibodies
0.49
1989
TEKES[1] funding received for the electronic and mechanical pipettors, pipettor tips as well as microplates
0.12
1988
Establishment of Biohit Oy
Electonic pipettor development begins
Establishment of Locus genex Oy, the current diagnostics division of the Biohit Group